Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide

<p>Abstract</p> <p>Background</p> <p>The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in the Alzheimer's disease brain. Amyloid-beta exists in different assembly forms in the aging mammalian brain including monomers,...

Full description

Bibliographic Details
Main Authors: O'Connor Peter B, Zhao Cheng, Yamin Rina, McKee Ann C, Abraham Carmela R
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Molecular Neurodegeneration
Online Access:http://www.molecularneurodegeneration.com/content/4/1/33
_version_ 1818790917525471232
author O'Connor Peter B
Zhao Cheng
Yamin Rina
McKee Ann C
Abraham Carmela R
author_facet O'Connor Peter B
Zhao Cheng
Yamin Rina
McKee Ann C
Abraham Carmela R
author_sort O'Connor Peter B
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in the Alzheimer's disease brain. Amyloid-beta exists in different assembly forms in the aging mammalian brain including monomers, oligomers, and aggregates, and in senile plaques, fibrils. Recent findings suggest that soluble amyloid-beta oligomers may represent the primary pathological species in Alzheimer's disease and the most toxic form that impairs synaptic and thus neuronal function. We previously reported the isolation of a novel amyloid-beta-degrading enzyme, acyl peptide hydrolase, a serine protease that degrades amyloid-beta, and is different in structure and activity from other amyloid-beta-degrading enzymes.</p> <p>Results</p> <p>Here we report the further characterization of acyl peptide hydrolase activity using mass spectrometry. Acyl peptide hydrolase cleaves the amyloid-beta peptide at amino acids 13, 14 and 19. In addition, by real-time PCR we found elevated acyl peptide hydrolase expression in brain areas rich in amyloid plaques suggesting that this enzyme's levels are responsive to increases in amyloid-beta levels. Lastly, tissue culture experiments using transfected CHO cells expressing APP751 bearing the V717F mutation indicate that acyl peptide hydrolase preferentially degrades dimeric and trimeric forms of amyloid-beta.</p> <p>Conclusion</p> <p>These data suggest that acyl peptide hydrolase is involved in the degradation of oligomeric amyloid-beta, an activity that, if induced, might present a new tool for therapy aimed at reducing neurodegeneration in the Alzheimer's brain.</p>
first_indexed 2024-12-18T15:03:04Z
format Article
id doaj.art-3f3d08dd0d9a43baa20fbf4d478c577f
institution Directory Open Access Journal
issn 1750-1326
language English
last_indexed 2024-12-18T15:03:04Z
publishDate 2009-07-01
publisher BMC
record_format Article
series Molecular Neurodegeneration
spelling doaj.art-3f3d08dd0d9a43baa20fbf4d478c577f2022-12-21T21:03:51ZengBMCMolecular Neurodegeneration1750-13262009-07-01413310.1186/1750-1326-4-33Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptideO'Connor Peter BZhao ChengYamin RinaMcKee Ann CAbraham Carmela R<p>Abstract</p> <p>Background</p> <p>The abnormal accumulation of amyloid-beta peptide is believed to cause malfunctioning of neurons in the Alzheimer's disease brain. Amyloid-beta exists in different assembly forms in the aging mammalian brain including monomers, oligomers, and aggregates, and in senile plaques, fibrils. Recent findings suggest that soluble amyloid-beta oligomers may represent the primary pathological species in Alzheimer's disease and the most toxic form that impairs synaptic and thus neuronal function. We previously reported the isolation of a novel amyloid-beta-degrading enzyme, acyl peptide hydrolase, a serine protease that degrades amyloid-beta, and is different in structure and activity from other amyloid-beta-degrading enzymes.</p> <p>Results</p> <p>Here we report the further characterization of acyl peptide hydrolase activity using mass spectrometry. Acyl peptide hydrolase cleaves the amyloid-beta peptide at amino acids 13, 14 and 19. In addition, by real-time PCR we found elevated acyl peptide hydrolase expression in brain areas rich in amyloid plaques suggesting that this enzyme's levels are responsive to increases in amyloid-beta levels. Lastly, tissue culture experiments using transfected CHO cells expressing APP751 bearing the V717F mutation indicate that acyl peptide hydrolase preferentially degrades dimeric and trimeric forms of amyloid-beta.</p> <p>Conclusion</p> <p>These data suggest that acyl peptide hydrolase is involved in the degradation of oligomeric amyloid-beta, an activity that, if induced, might present a new tool for therapy aimed at reducing neurodegeneration in the Alzheimer's brain.</p>http://www.molecularneurodegeneration.com/content/4/1/33
spellingShingle O'Connor Peter B
Zhao Cheng
Yamin Rina
McKee Ann C
Abraham Carmela R
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
Molecular Neurodegeneration
title Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
title_full Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
title_fullStr Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
title_full_unstemmed Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
title_short Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
title_sort acyl peptide hydrolase degrades monomeric and oligomeric amyloid beta peptide
url http://www.molecularneurodegeneration.com/content/4/1/33
work_keys_str_mv AT oconnorpeterb acylpeptidehydrolasedegradesmonomericandoligomericamyloidbetapeptide
AT zhaocheng acylpeptidehydrolasedegradesmonomericandoligomericamyloidbetapeptide
AT yaminrina acylpeptidehydrolasedegradesmonomericandoligomericamyloidbetapeptide
AT mckeeannc acylpeptidehydrolasedegradesmonomericandoligomericamyloidbetapeptide
AT abrahamcarmelar acylpeptidehydrolasedegradesmonomericandoligomericamyloidbetapeptide